ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,455.21
0.38%
Dow Jones
40,008.39
0.61%
US Dollar vs MXN
18.8251
-0.01%
Brent Oil
79.835
0.27%
Bitcoin
58,502.18
-0.36%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
15/08/202406:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BLRXBioLineRx Ltd
15/08/202406:05Alliance NewsAlliance NewsRank Group swings to annual profit; dividends make post-Covid comebackLSE:RNKRank Group Plc
15/08/202406:05PR Newswire (US)Unlock Technologies Announces Closing of East West Bank Warehouse Facility
15/08/202406:05GlobeNewswire Inc.Cellebrite Announces Second-Quarter 2024 ResultsNASDAQ:CLBTCellebrite Digital Intelligence Ltd
15/08/202406:05PR Newswire (US)UNLOCKING THE FUTURE OF CRE: KCM'S VISIONARY APPROACH CAPITALIZES ON $2.2 TRILLION OPPORTUNITY
15/08/202406:05GlobeNewswire Inc.uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry DiseaseNASDAQ:QUREuniQure NV
15/08/202406:04GlobeNewswire Inc.Survey Results: InStride Releases Workforce Education Motivations Report
15/08/202406:03Business WireBob Moritz, Former PricewaterhouseCoopers Chairperson, Named to Walmart Board of DirectorsNYSE:WMTWalmart Inc
15/08/202406:03PR Newswire (US)Zoom Drain widens its Tennessee footprint with new location in Nashville
15/08/202406:03PR Newswire (US)Window Hero launches new drone-powered cleaning service and window film solutions
15/08/202406:02Business WireWalmart reports strong revenue growth of 4.8% with operating income growing faster at 8.5%; adjusted operating income up 7.2%NYSE:WMTWalmart Inc
15/08/202406:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENGENGlobal Corp
15/08/202406:01Business WireAarvik Therapeutics Announces Option Exercise by Collaboration Partner ArriVent BioPharma
15/08/202406:00Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNYSE:DMDesktop Metal Inc
15/08/202406:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:DRCTDirect Digital Holdings Inc
15/08/202406:00GlobeNewswire Inc.Bio-Path Holdings Reports Second Quarter 2024 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
15/08/202406:00GlobeNewswire Inc.Action1 Reaffirms SOC 2 Type II and ISO 27001:2022 Certifications, Reinforcing Commitment to Security
15/08/202406:00Business WireTenured Wireless Customers Experience Greater Satisfaction with Cost and Promotions, J.D. Power Finds
15/08/202406:00GlobeNewswire Inc.Brookfield Business Partners Announces Renewal of Normal Course Issuer Bids for Units and Exchangeable SharesNYSE:BBUCBrookfield Business Corporation
15/08/202406:00Business WireQUODD Powers Infosel with Comprehensive Market Data from QX Marketplace
15/08/202406:00GlobeNewswire Inc.ValOre Commences Geophysical Survey and Trenching ProgramKEQ0
15/08/202406:00Business WireIMFINZI® (durvalumab) granted Priority Review and Breakthrough Therapy Designation for patients with limited-stage small cell lung cancer in the USNASDAQ:AZNAstraZeneca PLC
15/08/202406:00GlobeNewswire Inc.Macerich Releases 2023 Corporate Responsibility ReportNYSE:MACMacerich Co
15/08/202406:00GlobeNewswire Inc.Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2024AMEX:MLSSMilestone Scientific Inc
15/08/202406:00GlobeNewswire Inc.TransCode Therapeutics Announces Phase 1 Clinical Trial InitiationNASDAQ:RNAZTransCode Therapeutics Inc
15/08/202406:00Business WireVeritone AI-Powered Solutions for Media and Entertainment Now Available in AWS MarketplaceNASDAQ:VERIVeritone Inc
15/08/202406:00Business WireGMS Announces Date for First Quarter Fiscal Year 2025 Earnings Release and Conference CallNYSE:GMSGMS Inc
15/08/202406:00GlobeNewswire Inc.CARP Announces Exciting New Partnership with Emerald CruisesTSXV:ZUMZoomermedia Limited
15/08/202406:00GlobeNewswire Inc.Solei Launches New THC Infused Sparkling Beverages and TopicalsTSX:TLRYTilray Brands Inc
15/08/202406:00GlobeNewswire Inc.Cellebrite Announces Redemption of All Outstanding WarrantsNASDAQ:CLBTWCellebrite Digital Intelligence Ltd

Su Consulta Reciente

NASDAQ
GOOGL
Alphabet
NASDAQ
MSFT
Microsoft
COIN
ETHUSD
Ethereum
FX
EURMXN
Euro vs MXN
AMEX
XLF
Financial Select Sector
NYSE
CVX
Chevron
NASDAQ
AMZN
Amazon.com
CCOM
US30
US 30
COIN
XRPUSD
Ripple
USOTC
BASFY
BASF (QX)
USOTC
ADDYY
Adidas (QX)
NYSE
KO
Coca Cola
COIN
SOLUSD
Solana
CCOM
US500
US 500
AMEX
XLV
Health Care Select Sector
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados